A citation-based method for searching scientific literature

Robert E Steinert, Joerg Schirra, Anne C Meyer-Gerspach, Philipp Kienle, Heiko Fischer, Felix Schulte, Burkhard Goeke, Christoph Beglinger. Am J Clin Nutr 2014
Times Cited: 34







List of co-cited articles
617 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.
Susan J Melhorn, Vidhi Tyagi, Anne Smeraglio, Christian L Roth, Ellen A Schur. Appetite 2014
13
92

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
35

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
35


A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
32

Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.
Diana L Williams, Denis G Baskin, Michael W Schwartz. Endocrinology 2009
227
29

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
969
29

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
J Schirra, K Sturm, P Leicht, R Arnold, B Göke, M Katschinski. J Clin Invest 1998
203
29

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
Adam M Deane, Nam Q Nguyen, Julie E Stevens, Robert J L Fraser, Richard H Holloway, Laura K Besanko, Carly Burgstad, Karen L Jones, Marianne J Chapman, Chris K Rayner,[...]. J Clin Endocrinol Metab 2010
172
29

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans.
Akila De Silva, Victoria Salem, Christopher J Long, Aidan Makwana, Rexford D Newbould, Eugenii A Rabiner, Mohammad A Ghatei, Stephen R Bloom, Paul M Matthews, John D Beaver,[...]. Cell Metab 2011
215
26

Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
26

Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
Mathias Nicolaus, Julia Brödl, Rainer Linke, Hans-Juergen Woerle, Burkhard Göke, Jörg Schirra. J Clin Endocrinol Metab 2011
56
26


Glucagon-like peptide-1: a potent regulator of food intake in humans.
J P Gutzwiller, B Göke, J Drewe, P Hildebrand, S Ketterer, D Handschin, R Winterhalder, D Conen, C Beglinger. Gut 1999
425
23

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Nils B Jørgensen, Carsten Dirksen, Kirstine N Bojsen-Møller, Siv H Jacobsen, Dorte Worm, Dorte L Hansen, Viggo B Kristiansen, Lars Naver, Sten Madsbad, Jens J Holst. Diabetes 2013
202
23

Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Marzieh Salehi, Torsten P Vahl, David A D'Alessio. J Clin Endocrinol Metab 2008
85
23

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
C Verdich, A Flint, J P Gutzwiller, E Näslund, C Beglinger, P M Hellström, S J Long, L M Morgan, J J Holst, A Astrup. J Clin Endocrinol Metab 2001
417
23

GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
Liselotte van Bloemendaal, Richard G IJzerman, Jennifer S Ten Kulve, Frederik Barkhof, Robert J Konrad, Madeleine L Drent, Dick J Veltman, Michaela Diamant. Diabetes 2014
193
23

Effect of peptide YY3-36 on food intake in humans.
Lukas Degen, Sibylle Oesch, Michel Casanova, Stefanie Graf, Silvia Ketterer, Juergen Drewe, Christoph Beglinger. Gastroenterology 2005
262
23

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty.
Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, Bolette Hartmann, André Wettergren, Lars B Svendsen, Søren Meisner, Claus Hovendal, Tina Vilsbøll, Filip K Knop,[...]. Am J Physiol Gastrointest Liver Physiol 2013
115
23

Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Robert E Steinert, Christine Feinle-Bisset, Lori Asarian, Michael Horowitz, Christoph Beglinger, Nori Geary. Physiol Rev 2017
295
23

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
452
20

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
Elisabeth B Rüttimann, Myrtha Arnold, Jacquelien J Hillebrand, Nori Geary, Wolfgang Langhans. Endocrinology 2009
202
20

Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.
Mukesh Punjabi, Myrtha Arnold, Elisabeth Rüttimann, Mariana Graber, Nori Geary, Gustavo Pacheco-López, Wolfgang Langhans. Endocrinology 2014
39
20

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
739
20

GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats.
Elisabeth B Rüttimann, Myrtha Arnold, Nori Geary, Wolfgang Langhans. Physiol Behav 2010
28
21

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
C Verdich, S Toubro, B Buemann, J Lysgård Madsen, J Juul Holst, A Astrup. Int J Obes Relat Metab Disord 2001
306
17

Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
Stephanie Sisley, Ruth Gutierrez-Aguilar, Michael Scott, David A D'Alessio, Darleen A Sandoval, Randy J Seeley. J Clin Invest 2014
235
17

Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans.
C Beglinger, L Degen, D Matzinger, M D'Amato, J Drewe. Am J Physiol Regul Integr Comp Physiol 2001
144
17

Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men.
N Geary, H R Kissileff, F X Pi-Sunyer, V Hinton. Am J Physiol 1992
100
17

Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.
Mahesh M Umapathysivam, Michael Y Lee, Karen L Jones, Christopher E Annink, Caroline E Cousins, Laurence G Trahair, Chris K Rayner, Marianne J Chapman, Michael A Nauck, Michael Horowitz,[...]. Diabetes 2014
89
17

Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.
C F Deacon, L Pridal, L Klarskov, M Olesen, J J Holst. Am J Physiol 1996
260
17

Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Ola Lindgren, Richard D Carr, Carolyn F Deacon, Jens J Holst, Giovanni Pacini, Andrea Mari, Bo Ahrén. J Clin Endocrinol Metab 2011
137
17

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
601
17

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, H J Woerle, B Göke. Gut 2006
202
17


Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Maria S Svane, Kirstine N Bojsen-Møller, Signe Nielsen, Nils B Jørgensen, Carsten Dirksen, Flemming Bendtsen, Viggo B Kristiansen, Bolette Hartmann, Jens J Holst, Sten Madsbad. Am J Physiol Endocrinol Metab 2016
47
17

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
C Dirksen, N B Jørgensen, K N Bojsen-Møller, U Kielgast, S H Jacobsen, T R Clausen, D Worm, B Hartmann, J F Rehfeld, M Damgaard,[...]. Int J Obes (Lond) 2013
175
17

Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.
Benedikt A Aulinger, Anne Bedorf, Gabriele Kutscherauer, Jocelyn de Heer, Jens J Holst, Burkhard Göke, Jörg Schirra. Diabetes 2014
71
17

Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
M S Svane, N B Jørgensen, K N Bojsen-Møller, C Dirksen, S Nielsen, V B Kristiansen, S Toräng, N J Wewer Albrechtsen, J F Rehfeld, B Hartmann,[...]. Int J Obes (Lond) 2016
111
17

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
Carel W le Roux, Simon J B Aylwin, Rachel L Batterham, Cynthia M Borg, Frances Coyle, Vyas Prasad, Sandra Shurey, Mohammad A Ghatei, Ameet G Patel, Stephen R Bloom. Ann Surg 2006
706
17

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
A Wettergren, B Schjoldager, P E Mortensen, J Myhre, J Christiansen, J J Holst. Dig Dis Sci 1993
547
17

Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
739
17

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
14


Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
J P Gutzwiller, J Drewe, B Göke, H Schmidt, B Rohrer, J Lareida, C Beglinger. Am J Physiol 1999
315
14


Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.
Richard E Pratley, Michael A Nauck, Anthony H Barnett, Mark N Feinglos, Fernando Ovalle, Illana Harman-Boehm, June Ye, Rhona Scott, Susan Johnson, Murray Stewart,[...]. Lancet Diabetes Endocrinol 2014
224
14

Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men.
Ixchel M Brennan, Natalie D Luscombe-Marsh, Radhika V Seimon, Bärbel Otto, Michael Horowitz, Judith M Wishart, Christine Feinle-Bisset. Am J Physiol Gastrointest Liver Physiol 2012
127
14

Critical role for peptide YY in protein-mediated satiation and body-weight regulation.
Rachel L Batterham, Helen Heffron, Saloni Kapoor, Joanna E Chivers, Keval Chandarana, Herbert Herzog, Carel W Le Roux, E Louise Thomas, Jimmy D Bell, Dominic J Withers. Cell Metab 2006
401
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.